Analytical developoment and quality control plays pivotal roles in drug development. Validated and ready-to-use analytical tools can streamline the process and accelerate regulatory approvals.    

GenScript offers a comprehensive suite of analytical and quality control (QC) solutions to accelerate the development and manufacturing of advanced therapeutics for oncology research and treatment development, spanning from cell therapies to antibody drugs. Our portfolio includes our first-to-market universal and high-specificity CAR-detection antibodies, ultra-sensitive and fast-protocol ELISA kits, and stable cell lines of ADC targets and immune checkpoint targets. Together, these products empower biopharmaceutical developers with end-to-end analytical capabilities that enhance accuracy, throughput, and confidence from early discovery through commercial manufacturing.

Learning Objectives:

1. How can universal CAR detection antibody escalate CAR-based cell therapy development?

2. How can fast-protocol ELISA kits streamline your analytical and QC workflow?

3. How can ready-to-use stable cell lines for immune checkpoints and ADC targets speed up your oncology drug discovery and development?